Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03039634 · ClinicalTrials.gov registry record

Long-term Follow-up Study of Subjects Who Completed Clinical Studies 755.1100_FA, 810.1100_FA, or 1064.1100_FA

A clinical trial of Acne Vulgaris, sponsored by Sienna Labs.

Completed
Registry status
76
Enrollment target
16
Study locations

NCT03039634 is a study of Acne Vulgaris that has completed, run by Sienna Labs. The registered enrollment target is 76 participants, below the 274-participant average among 67 other Acne Vulgaris trials with a reported enrollment target (72% lower). The trial reports 16 study locations across 13 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03039634, a study of Acne Vulgaris, has completed, sponsored by Sienna Labs.

COMPLETED
Registry status
76 participants
Enrollment target
16
Study locations

Study Summary

This study evaluates the safety, effectiveness, and maintenance of effect of a novel topical silver particle solution (Sienna 755.1100, 810.1100, or 1064.1100) used in conjunction with a laser for the treatment of Acne Vulgaris.

Conditions Studied

Acne Vulgaris

Study Locations (16)

Texas

  • - Houston
  • - Pflugerville
  • - San Antonio

Florida

  • - Coral Gables
  • - Miami

Arizona

  • - Scottsdale

California

  • - Santa Monica

Maryland

  • - Hunt Valley

Massachusetts

  • - Beverly

Missouri

  • - St Louis

New Jersey

  • - Hackensack

Trial Details

FieldValue
Enrollment Target 76 participants
Start Date 2016-08
Est. Completion 2018-05

Sponsor

Sienna Labs

1 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT03039634

The ClinicalTrials.gov registry entry for NCT03039634 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 76 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 274-participant average among 67 other Acne Vulgaris trials with a reported enrollment target (72% lower). The listed sponsor is Sienna Labs, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Acne Vulgaris appearing as the primary indexed condition, and to 0 interventions.

NCT03039634 reports 16 study locations spanning 13 distinct geographic areas - top geographies include Texas, Florida, Arizona.

Frequently Asked Questions

What is clinical trial NCT03039634 about?

NCT03039634 is a clinical study titled "Long-term Follow-up Study of Subjects Who Completed Clinical Studies 755.1100_FA, 810.1100_FA, or 1064.1100_FA". This study evaluates the safety, effectiveness, and maintenance of effect of a novel topical silver particle solution (Sienna 755.1100, 810.1100, or 1064.1100) used in conjunction with a laser for the treatment of Acne Vulgaris.

What is the current status of trial NCT03039634?

This trial is currently completed. The enrollment target is 76 participants. The study started on 2016-08. Estimated completion is 2018-05.

What conditions does trial NCT03039634 study?

This clinical trial studies the following conditions: Acne Vulgaris.

Who is sponsoring clinical trial NCT03039634?

This trial is sponsored by Sienna Labs, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03039634 being conducted?

This trial has 16 study locations across Arizona, California, Florida, Maryland, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Acne Vulgaris

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Acne Vulgaris

All registered trials for this condition

Arizona

All trials with a study site in Arizona

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.